Research theme for competitive and other funds (5)：
2020 - 2023 p68の肝癌細胞及び肝癌血管内皮細胞における機能解析
2019 - 2022 Interaction between hepatocytes and stellate cells in NASH
2019 - 2022 肝炎等克服実用化研究事業(肝炎等克服緊急対策研究事業
2016 - 2019 肝線維化からみた肝発癌メカニズムの解明と新規治療法の開発
2012 - 2016 The new therapy of liver cirrhosis which inhibit the progression fibrosis
Papers (22)：
Daisuke Kato, Takanori Suzuki, Kentaro Matsuura, Kohei Okayama, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Katsumi Hayashi, Atsunori Kusakabe, Izumi Hasegawa, et al. Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study. Oncology. 2024. 1-9
Takanori Suzuki, Kentaro Matsuura, Naoto Imura, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Shogo Ito, Takao Togawa, Hiromi Kataoka. Adult-onset Type II Citrullinemia Developed under Dietary Restrictions during Imprisonment. Internal medicine (Tokyo, Japan). 2024. 63. 6. 833-837
Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Daisuke Kato, Atsunori Kusakabe, Hiroki Koguchi, Izumi Hasegawa, et al. Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study. Oncology. 2024. 1-12
Yoshihito Nagura, Takanori Suzuki, Kentaro Matsuura, Shintaro Ogawa, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Katsuya Nagaoka, Etsuko Iio, et al. Serum inducible protein 10 kDa/C-X-C motif chemokine 10 levels predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. Hepatology research : the official journal of the Japan Society of Hepatology. 2024. 54. 1. 32-42
Takanori Suzuki, Kentaro Matsuura, Takehisa Watanabe, Takeshi Matsui, Shintaro Ogawa, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Hiromi Kataoka, et al. Kinetics of HBcrAg and HBsAg using highly sensitive iTACT assays in chronic hepatitis B patients with HBsAg seroclearance. Journal of medical virology. 2023. 95. 9. e29109
Kentaro Matsuura, Etsuko Iio, Nobuhiro Aizawa, Hirayuki Enomoto, Shuhei Nishiguchi, Hidenori Toyoda, Takashi Kumada, Kayoko Matsunami, Kei Fujiwara, Shunsuke Nojiri, et al. Circulating let-7 levels in serum and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C. HEPATOLOGY. 2017. 66. 238A-239A
Etsuko Iio, Noritomo Shimada, Kentaro Matsuura, Masanori Atsukawa, Koichi Takaguchi, Yuichiro Eguchi, Hideyuki Nomura, Noboru Hirashima, Akihito Tsubota, Atsunori Kusakabe, et al. Investigating the association of TLL1 variant with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free regimens. HEPATOLOGY. 2017. 66. 521A-521A
Takako Inoue, Takaaki Goto, Etsuko Iio, Kayoko Matsunami, Kei Fujiwara, Noboru Shinkai, Kentaro Matsuura, Shunsuke Nojiri, Yasuhito Tanaka. Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virus. HEPATOLOGY. 2017. 66. 476A-476A
Shunsuke Nojiri, Kei Fujiwara, Noboru Shinkai, Etsuko Iio, Takashi Joh. The Dead Box Protein P68 Can Supress The Carcinogenesis And A-Fetoprotein (AFP) Gene Expression via Binding The New Silencer Region Of AFP Gene. HEPATOLOGY. 2015. 62. 1160A-1161A
2011/11 - AASLD 2011 AASLD presidential Poster of Distinction
Association Membership(s) (5)：
THE JAPAN SOCIETY FOR ORIENTAL MEDICINE
, The Japan Society of Hepatology
, JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY
, The Japanese Society of Gastroenterology
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
